Literature DB >> 20478698

Effect of Met66 allele of the BDNF rs6265 SNP on regional gray matter volumes in patients with multiple sclerosis: A voxel-based morphometry study.

Deepa P Ramasamy1, Murali Ramanathan, Jennifer L Cox, Ronald Antulov, Bianca Weinstock-Guttman, Niels Bergsland, Ralph H B Benedict, Michael G Dwyer, Alireza Minagar, Robert Zivadinov.   

Abstract

The rs6265 single nucleotide polymorphism (SNP) is a genetic variation in the brain-derived neurotrophic factor (BDNF) gene wherein the presence of the A-allele at rs6265 causes replacement of a valine (Val) at position 66 by methionine (Met). We reported recently that the Met66 allele was associated with lower brain damage as evidenced by measurement of gray matter (GM) volume in multiple sclerosis (MS) patients. The objective of this study was to determine the voxel-wise regional GM differences between the Val66Val and Met66 allele groups in MS patients by using voxel-based morphometry (VBM)-optimized analysis corrected for lesion misclassification in Statistical Parametric Mapping (SPM5). High-resolution 3D-T1-weighted SPGR images from a total of 188 MS patients were acquired on a 1.5T MRI. The Val66Val group included 129 MS patients and the Met66 allele group (comprised of Val66Met or Met66Met genotypes) included 59 MS patients. The SPM analysis of covariance tool was used to assess group differences after controlling for variation in head size, MS disease course and gender. VBM analysis did not yield significant family wise error (FWE) corrected results. This was also confirmed with the non-parametric analysis using threshold-free cluster enhancement (TFCE) method. However, the results from VBM as well as the TFCE analyses (p<0.001, uncorrected) showed higher GM volume in the cingulate of MS patients with Met66 allele than those with Val66Val. Future studies are warranted to investigate longitudinally possible protective role of the Met66 allele of the BDNF rs6265 SNP in relation to specific GM regions. Copyright Â
© 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Year:  2010        PMID: 20478698     DOI: 10.1016/j.pathophys.2010.04.006

Source DB:  PubMed          Journal:  Pathophysiology        ISSN: 0928-4680


  15 in total

1.  Effect of BDNF Val66Met polymorphism on hippocampal subfields in multiple sclerosis patients.

Authors:  Ermelinda De Meo; Emilio Portaccio; Elio Prestipino; Benedetta Nacmias; Silvia Bagnoli; Lorenzo Razzolini; Luisa Pastò; Claudia Niccolai; Benedetta Goretti; Angelo Bellinvia; Mattia Fonderico; Antonio Giorgio; Maria Laura Stromillo; Massimo Filippi; Sandro Sorbi; Nicola De Stefano; Maria Pia Amato
Journal:  Mol Psychiatry       Date:  2021-10-14       Impact factor: 15.992

Review 2.  Brain-derived neurotrophic factor rs6265 (Val66Met) single nucleotide polymorphism as a master modifier of human pathophysiology.

Authors:  Van Thuan Nguyen; Braxton Hill; Naiya Sims; Aaron Heck; Marcus Negron; Claire Lusk; Cristi L Galindo
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

Review 3.  BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases.

Authors:  Bai Lu; Guhan Nagappan; Xiaoming Guan; Pradeep J Nathan; Paul Wren
Journal:  Nat Rev Neurosci       Date:  2013-05-15       Impact factor: 34.870

4.  Effect of the BDNF Val66Met polymorphism on regional gray matter volumes and cognitive function in the Chinese population.

Authors:  Mu-En Liu; Chu-Chung Huang; Mu-Hong Chen; Albert C Yang; Pei-Chi Tu; Heng-Liang Yeh; Chen-Jee Hong; Jin-Fan Chen; Jen-Ping Hwang; Ching-Po Lin; Shih-Jen Tsai
Journal:  Neuromolecular Med       Date:  2013-12-24       Impact factor: 3.843

Review 5.  Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.

Authors:  Manuel A Friese; Benjamin Schattling; Lars Fugger
Journal:  Nat Rev Neurol       Date:  2014-03-18       Impact factor: 42.937

6.  The BDNF Val66Met polymorphism has opposite effects on memory circuits of multiple sclerosis patients and controls.

Authors:  Francesco Fera; Luca Passamonti; Antonio Cerasa; Maria Cecilia Gioia; Maria Liguori; Ida Manna; Paola Valentino; Aldo Quattrone
Journal:  PLoS One       Date:  2013-04-11       Impact factor: 3.240

7.  Effects of the BDNF Val66Met Polymorphism on Gray Matter Volume in Typically Developing Children and Adolescents.

Authors:  Teruo Hashimoto; Kento Fukui; Hikaru Takeuchi; Susumu Yokota; Yoshie Kikuchi; Hiroaki Tomita; Yasuyuki Taki; Ryuta Kawashima
Journal:  Cereb Cortex       Date:  2016-01-31       Impact factor: 5.357

8.  Dose-dependent genotype effects of BDNF Val66Met polymorphism on default mode network in early stage Alzheimer's disease.

Authors:  Pin-Hsuan Lin; Shih-Jen Tsai; Chi-Wei Huang; Liu Mu-En; Shih-Wei Hsu; Chen-Chang Lee; Nai-Ching Chen; Ya-Ting Chang; Min-Yu Lan; Chiung-Chih Chang
Journal:  Oncotarget       Date:  2016-08-23

Review 9.  BDNF Polymorphism: A Review of Its Diagnostic and Clinical Relevance in Neurodegenerative Disorders.

Authors:  Ting Shen; Yuyi You; Chitra Joseph; Mehdi Mirzaei; Alexander Klistorner; Stuart L Graham; Vivek Gupta
Journal:  Aging Dis       Date:  2018-06-01       Impact factor: 6.745

10.  BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression.

Authors:  Viviana Nociti; Massimo Santoro; Davide Quaranta; Francesco Antonio Losavio; Chiara De Fino; Rocco Giordano; Nicole Piera Palomba; Paolo Maria Rossini; Franca Rosa Guerini; Mario Clerici; Domenico Caputo; Massimiliano Mirabella
Journal:  PLoS One       Date:  2018-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.